Through our analysis of KLF3 in pan-cancer, we found that KLF3 is significantly upregulated in PAAD (Figures 1A–C) and its expression positively correlates with patient clinical stage and histological grade (Figures 3A, B). Here, KLF3 is linked to pancreatic adenocarcinoma.